Clinical trial
CINJALL: Treatment for Children With Acute Lymphocytic Leukemia
NCT00176462 · Rutgers, The State University of New Jersey, Other · Completed
Key facts
| NCT number | NCT00176462 |
|---|---|
| Title | CINJALL: Treatment for Children With Acute Lymphocytic Leukemia |
| Official title | CINJALL: Treatment for Children With Acute Lymphocytic Leukemia |
| Lead sponsor | Rutgers, The State University of New Jersey, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | aminopterin, L-asparaginase, cyclophosphamide, cytarabine, daunomycin, dexamethasone, 6-mercaptopurine, methotrexate, 6-thioguanine, vincristine and 4 more |
| Enrollment | 60 |
| Start date | Feb 1, 2001 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: